Intchains Group Ltd
NASDAQ:ICG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Intchains Group Ltd
NASDAQ:ICG
|
CN |
|
Nick Scali Ltd
ASX:NCK
|
AU |
|
THG PLC
LSE:THG
|
UK |
|
Trans Power Marine Tbk PT
IDX:TPMA
|
ID |
|
H
|
Habco Trans Maritima Tbk PT
IDX:HATM
|
ID |
|
P
|
Pharmacom Biovet Inc
OTC:PHMB
|
US |
|
OKP Holdings Ltd
SGX:5CF
|
SG |
Intchains Group Ltd
Intchains Group Ltd. operates as an ASIC chip design company. The company is headquartered in Shanghai, Shanghai and currently employs 101 full-time employees. The company went IPO on 2023-03-16. The firm has built a proprietary technology platform named Xihe Platform, which allows to develop ASIC chips.
Intchains Group Ltd. operates as an ASIC chip design company. The company is headquartered in Shanghai, Shanghai and currently employs 101 full-time employees. The company went IPO on 2023-03-16. The firm has built a proprietary technology platform named Xihe Platform, which allows to develop ASIC chips.
Revenue Drop: Full year 2025 revenue fell 21.6% to $31.6 million due to cyclical market fluctuations and softer demand in the second half.
Product Innovation: Multiple new altcoin mining products launched in 2025, notably ALEO and XTM miners, helped drive first-half sales and reinforced market positioning.
ETH Accumulation: ETH holdings grew 56% in 2025, reaching 8,826 ETH by year-end and surpassing 9,000 ETH by February 2026.
Staking Expansion: Launched Goldshell Stake platform in December 2025, offering staking services to both individual and institutional clients and partnering with FalconX for ETH staking.
Cost Controls: Initiated workforce reduction and restructuring in 2026 to improve efficiency and margins, aiming for margin expansion going forward.
China Regulation: New restrictions on mining machine sales in Mainland China cited, but management does not expect a material adverse impact due to global customer focus.
2026 Outlook: Focus remains on R&D, ETH accumulation and staking, and further product launches are targeted in the second half of 2026, subject to market and R&D progress.
